Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,234.00    -22.00 (-1.75%)
Bid:
1,234.00
Ask:
1,238.00
Spread: 4.00 (0.324%)
Market Cap: £565.49m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Contract Win

13 Aug 2015 07:00

RNS Number : 9010V
Cohort PLC
13 August 2015
 



13 August 2015

Cohort plc

("Cohort" or "the Group")

 

Cohort's MCL subsidiary wins MOD hearing protection contract

 

Cohort, the independent technology group, is pleased to announce that its subsidiary Marlborough Communications Ltd. (MCL) has been awarded a contract by the UK Ministry of Defence to provide the armed forces with tactical hearing protection systems for the dismounted close combat user ("THPS DCCU"). The award follows a competitive tender process.

 

The initial order value is £11.2m. Further orders are expected over the duration of the contract and the delivery schedule and total contract value are still the subject of discussion with the customer. The contract has been awarded for four years, with an option to extend it for a further three years.

 

The solution being supplied by MCL was developed in partnership with INVISIO Communications, a leading Danish audio technology company.

 

This contract win follows on from MCL's previous UK MOD win earlier in the year, supplying its Tactical In-Ear Protection Plugs as part of the tactical hearing protection system for the basic user soldier.

 

Andrew Thomis, Chief Executive of Cohort plc, said:

"We are delighted that MCL has been awarded the THPS DCCU contract. We look forward to working with the UK MOD to deliver this important equipment to soldiers.

"The contract will add significantly to our already strong order book, which substantially underpins our revenues for Cohort's current financial year."

 

ENDS

 

 

For further information please contact:

Cohort plc

Andy Thomis, Chief Executive

Simon Walther, Finance Director

 

0118 909 0390

Investec Bank plc

Keith Anderson / Daniel Adams

020 7597 5970

MHP Communications Limited

Reg Hoare / Jamie Ricketts

020 3128 8100

 

NOTES TO EDITORS

 

Cohort plc (www.cohortplc.com) is the parent company for four innovative, agile and responsive businesses working primarily for defence, wider government and industry clients.

 

· SCS (www.scs-ltd.co.uk) - a defence consultancy, combining technical expertise with armed forces experience and domain knowledge. Owned by Cohort since flotation in March 2006.

· MASS (www.mass.co.uk) - a specialist defence and technology business, focused mainly on electronic warfare, information systems and cyber security. Acquired by Cohort in August 2006.

· SEA (www.sea.co.uk) - an advanced electronic systems and software house operating in the defence, transport and offshore energy markets. Acquired by Cohort in October 2007.

 

· MCL (www.marlboroughcomms.com) - an expert in sourcing, design and integration of communications and surveillance technology, as well as support and training for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014.

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 650 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Devon, Lincolnshire, Somerset, Surrey and Scotland.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTPKBDKABKDQFD
Date   Source Headline
30th Jan 20187:00 amRNSContract Announcement
10th Jan 20185:08 pmRNSEBT Purchase
5th Jan 20189:48 amRNSInterim Report 2017
15th Dec 201710:08 amRNSHolding(s) in Company
13th Dec 201711:58 amRNSRevised dividend timetable
13th Dec 20178:51 amEQSEdison Investment Research Limited: Edison issues outlook on Cohort (CHRT)
13th Dec 20177:00 amRNSContract Announcement
13th Dec 20177:00 amRNSHalf-year Results
28th Nov 20177:00 amRNSHolding(s) in Company
27th Nov 20177:00 amRNSAcquisition and Trading Update
17th Oct 20179:24 amRNSDirector/PDMR Shareholding
21st Sep 20173:22 pmRNSNotice of Half Year Results
13th Sep 20174:52 pmRNSDirector/PDMR Shareholding
7th Sep 20176:09 pmRNSResult of AGM
7th Sep 20177:00 amRNSAGM Statement
6th Sep 20173:00 pmRNSDirector Share Awards
6th Sep 20172:59 pmRNSEBT Purchase
24th Aug 20179:21 amRNSDirector/PDMR Shareholding
22nd Aug 20179:24 amRNSMCL acquisition final instalment paid
15th Aug 201710:29 amRNSDirector/PDMR Shareholding
2nd Aug 201710:56 amRNSAnnual Report
1st Aug 20177:00 amRNSContract Announcement
29th Jun 20177:00 amRNSFinal Results
28th Jun 20179:50 amRNSHolding(s) in Company
21st Jun 20173:03 pmRNSHolding(s) in Company
2nd Jun 20177:00 amRNSContract Announcement
31st May 20172:09 pmRNSNotice of Results
9th May 201710:42 amRNSDirector/PDMR Shareholding
4th Apr 20176:32 pmRNSHolding(s) in Company
4th Apr 20176:32 pmRNSHolding(s) in Company
16th Mar 20173:59 pmRNSDirector/PDMR Shareholding
9th Mar 20178:00 amRNSContract Announcement
9th Feb 20173:44 pmRNSHolding(s) in Company
1st Feb 20177:00 amRNSAcquisition
25th Jan 20179:48 amRNSContract Announcement
9th Jan 20177:00 amRNSReplacement: Contract Announcement
6th Jan 20176:29 pmRNSAcquisition Announcement
6th Jan 201710:21 amRNSInterim Report
28th Dec 20167:00 amRNSHolding(s) in Company
12th Dec 20162:16 pmEQSEQS-News: Edison Investment Research Limited: Edison issues update on Cohort (CHRT)
12th Dec 20167:00 amRNSHalf-year Report
9th Dec 20167:00 amRNSDirector/PDMR Shareholding
7th Nov 20167:00 amRNSContract Win
21st Oct 201612:53 pmRNSDirector/PDMR Shareholding
17th Oct 20167:00 amRNSContract Win
14th Oct 20165:14 pmRNSDirector/PDMR Shareholding
11th Oct 20167:00 amRNSReorganisation at SCS
7th Oct 20164:11 pmRNSDirector/PDMR Shareholding
7th Oct 20164:05 pmRNSDirector/PDMR Shareholding
4th Oct 20167:00 amRNSCapital Markets Event

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.